Back to Search Start Over

Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma

Authors :
Qin‑Hai Shen
Xi Chen
Qiao‑Ling Wang
Meng‑Hui Zhang
Zhao‑Min Qin
Source :
Oncology Letters
Publication Year :
2016
Publisher :
Spandidos Publications, 2016.

Abstract

The objective of the present study is to identify significant genes and pathways associated with hepatocellular carcinoma (HCC) by systematically tracking the dysregulated modules of re-weighted protein-protein interaction (PPI) networks. Firstly, normal and HCC PPI networks were inferred and re-weighted based on Pearson correlation coefficient. Next, modules in the PPI networks were explored by a clique-merging algorithm, and disrupted modules were identified utilizing a maximum weight bipartite matching in non-increasing order. Then, the gene compositions of the disrupted modules were studied and compared with differentially expressed (DE) genes, and pathway enrichment analysis for these genes was performed based on Expression Analysis Systematic Explorer. Finally, validations of significant genes in HCC were conducted using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. The present study evaluated 394 disrupted module pairs, which comprised 236 dysregulated genes. When the dysregulated genes were compared with 211 DE genes, a total of 26 common genes [including phospholipase C beta 1, cytochrome P450 (CYP) 2C8 and CYP2B6] were obtained. Furthermore, 6 of these 26 common genes were validated by RT-qPCR. Pathway enrichment analysis of dysregulated genes demonstrated that neuroactive ligand-receptor interaction, purine and drug metabolism, and metabolism of xenobiotics mediated by CYP were significantly disrupted pathways. In conclusion, the present study greatly improved the understanding of HCC in a systematic manner and provided potential biomarkers for early detection and novel therapeutic methods.

Details

ISSN :
17921082 and 17921074
Volume :
12
Database :
OpenAIRE
Journal :
Oncology Letters
Accession number :
edsair.doi.dedup.....d58928b2a57fb6674c89cde48b331cfc
Full Text :
https://doi.org/10.3892/ol.2016.5039